Table 1.
Summary of the Patients’ Clinical and Pathologic Features.
| Variable | Frequency | Percentage |
|---|---|---|
| Age | ||
| ≤62 | 19 | 57.60 |
| >62 | 14 | 42.40 |
| Histology | ||
| Serous | 29 | 87.90 |
| Others | 4 | 12.10 |
| FIGO stage | ||
| III | 26 | 78.79 |
| IV | 3 | 9.09 |
| X | 4 | 12.12 |
| Differentiation | ||
| Well-moderate | 7 | 21.20 |
| Poor | 26 | 78.80 |
| Debulking | ||
| Optimal | 26 | 78.80 |
| Suboptimal | 7 | 21.20 |
| Lymph node | ||
| Negative | 13 | 39.40 |
| Positive | 14 | 42.40 |
| Unconfirmed | 6 | 18.20 |
| Chemoresponse | ||
| Sensitive | 15 | 45.50 |
| Resistance | 18 | 54.50 |
Abbreviation: FIGO, International Federation of Gynecology and Obstetrics.